[1]高凤霞.沐舒坦雾化吸入联合静脉注射治疗新生儿肺炎的效果分析[J].医学信息,2018,31(04):12-14.[doi:10.3969/j.issn.1006-1959.2018.04.005]
　GAO Feng-xia.Effect of Atomization Inhalation of Ambroxol Combined with Intravenous Injection in the Treatment of Neonatal Pneumonia[J].Medical Information,2018,31(04):12-14.[doi:10.3969/j.issn.1006-1959.2018.04.005]
点击复制

沐舒坦雾化吸入联合静脉注射治疗新生儿肺炎的效果分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年04期
页码:
12-14
栏目:
出版日期:
2018-02-15

文章信息/Info

Title:
Effect of Atomization Inhalation of Ambroxol Combined with Intravenous Injection in the Treatment of Neonatal Pneumonia
文章编号:
1006-1959（2018）04-0012-03
作者:
高凤霞
天津滨海新区塘沽妇产医院儿科，天津 300451
Author(s):
GAO Feng-xia
Department of Pediatrics,Tanggu Maternity Hospital,Tianjin Binhai New District,Tianjin 300451,China
关键词:
新生儿肺炎; 沐舒坦; 静脉注射; 雾化吸入
Keywords:
Key words：Neonatal pneumonia; Ambroxol; Intravenous injection; Atomization inhalation
分类号:
R722.13+5
DOI:
10.3969/j.issn.1006-1959.2018.04.005
文献标志码:
A
摘要:
目的 研究沐舒坦雾化吸入联合静脉注射治疗新生儿肺炎的效果。方法 本次选取研究对象为2016年2月8日~2017年2月11日在我院进行治疗的肺炎患儿，根据治疗方式分为观察组与对照组，各34例。对照组患儿采用沐舒坦静脉注射，观察组在此基础上加用雾化吸入治疗。将两组肺炎患儿的临床症状消失时间、临床效果、不良反应发生情况以及患儿家长治疗满意度进行比对。结果 组间对比临床症状消失时间，观察组肺炎患儿更短，差异有统计学意义（P＜0.05）；观察组肺炎患儿的临床总有效率（97.06%）高于对照组，差异有统计学意义（P＜0.05）；两组的不良反应发生率进行比较差异不大，无统计学意义（P＞0.05）。结论 沐舒坦是治疗新生儿肺炎的有效方法，采用静脉注射联合雾化吸入进行治疗具有改善临床症状且安全性高的特点。
Abstract:
Abstract：Objective To study the ambroxol aerosol inhalation combined with intravenous injection in the treatment of neonatal pneumonia.Methods The research object for the February 8,2016 ~2017 year in February 11th for the treatment of children with pneumonia in our hospital,according to the treatment methods are divided into observation group and control group,34 cases in each group.The control group was injected with ambroxol intravenously,the observation group was treated with atomization inhalation on the basis of this.The time of disappearance of clinical symptoms,the clinical effect,the occurrence of adverse reaction and the satisfaction of the parents in the two groups of children with pneumonia were compared.Results The clinical symptoms disappeared time comparison between the two groups,the observation group of children with pneumonia is shorter,the difference was statistically significant(P<0.05);clinical observation of children with pneumonia group total efficiency(97.06%)was higher than the control group, the difference was statistically significant(P<0.05);the adverse reactions of the two groups were compared the incidence of little difference,no statistical significance(P>0.05).Conclusion Ambroxol is an effective method in the treatment of neonatal pneumonia. The combination of intravenous injection and atomization inhalation has the characteristics of improving clinical symptoms and high safety.

参考文献/References:

[1]付朝阳.沐舒坦雾化吸入联合静脉注射治疗新生儿肺炎的临床疗效观察[J].中国妇幼保健,2015,30(15):2442-2444.
[2]潘冬梅.沐舒坦雾化吸入联合静脉注射治疗新生儿肺炎的疗效观察[J].医学信息,2017,30(15):99-100.
[3]吴复栋.沐舒坦雾化吸入联合丙种球蛋白静脉滴注治疗新生儿肺炎的效果[J].国际医药卫生导报,2016,22(18):2832-2835.
[4]郑香顺.采用雾化吸入联合静脉注射的方式用沐舒坦治疗新生儿肺炎的效果观察[J].当代医药论丛,2016,14(17):37-38.
[5]胡德飞,罗孝华,钟世冰.静脉滴注加雾化吸入沐舒坦治疗新生儿肺炎的疗效评价[J].基层医学论坛,2016,20(36):5087-5088.
[6]范于娥.静脉滴注加雾化吸入沐舒坦治疗新生儿肺炎的临床效果探讨[J].医学理论与实践,2016,29(7):935-936.
[7]陈茵.沐舒坦雾化吸入联合静脉注射治疗新生儿肺炎的临床疗效[J].临床合理用药杂志,2015，8(24):32-33.
[8]张忠山.沐舒坦雾化吸入结合静脉滴注治疗新生儿肺炎的疗效观察[J].临床医药文献电子杂志,2016,3(35):7045-7046.
[9]谭鑫.沐舒坦雾化吸入治疗新生儿肺炎疗效观察[J].中国实用医刊,2015,42(24):117-118.
[10]黄可丹.新生儿肺炎给予沐舒坦雾化吸入联合静脉注射的疗效研究[J].中国妇幼保健,2014,29(4):621-623.
[11]苏增玲,黄海波,温艳芬,等.沐舒坦雾化吸入结合静脉滴注治疗新生儿肺炎的临床效果[J].中国医药指南,2014,12(18):173-174.
[12]翁志国.沐舒坦雾化吸入辅助治疗新生儿肺炎的临床疗效[J].当代医药论丛,2014(11):190-191.

相似文献/References:

[1]史贻芳.普米克令舒联合氨溴索治疗新生儿肺炎的临床疗效观察[J].医学信息,2018,31(04):132.[doi:10.3969/j.issn.1006-1959.2018.04.047]
　SHI Yi-fang.Clinical Effect of Pulmicort Combined with Ambroxol in the Treatment of Neonatal Pneumonia[J].Medical Information,2018,31(04):132.[doi:10.3969/j.issn.1006-1959.2018.04.047]
[2]李凤利,陈 伟,张 林.不同剂量沐舒坦在肺癌围术期的肺功能保护作用[J].医学信息,2018,31(07):128.[doi:10.3969/j.issn.1006-1959.2018.07.043]
　LI Feng-li,CHEN Wei,ZHANG Lin.Protective Effects of Different Doses of Ambroxol on Lung Function in Patients with Lung Cancer during Perioperative Period[J].Medical Information,2018,31(04):128.[doi:10.3969/j.issn.1006-1959.2018.07.043]
[3]许子贤,王 丹.BNP/NT-proBNP及心肌酶谱联合检测诊断新生儿肺炎的价值[J].医学信息,2021,34(17):107.[doi:10.3969/j.issn.1006-1959.2021.17.027]
　XU Zi-xian,WANG Dan.The Value of Combined Detection of BNP/NT-proBNP and Myocardial Enzyme Spectrum in the Diagnosis of Neonatal Pneumonia[J].Medical Information,2021,34(04):107.[doi:10.3969/j.issn.1006-1959.2021.17.027]
[4]淦作洪.白细胞计数、心肌标志物、C反应蛋白在新生儿肺炎中的临床意义[J].医学信息,2023,36(16):148.[doi:10.3969/j.issn.1006-1959.2023.16.030]
　GAN Zuo-hong.Clinical Significance of White Blood Cell Count, Myocardial Markers and C-reactive Protein in Neonatal Pneumonia[J].Medical Information,2023,36(04):148.[doi:10.3969/j.issn.1006-1959.2023.16.030]
[5]曾祥斌,邓嘉奇,张鹏飞,等.干扰素γ与沐舒坦联合雾化吸入治疗慢性支气管炎急性发作的临床疗效[J].医学信息,2024,37(20):123.[doi:10.3969/j.issn.1006-1959.2024.20.025]
　ZENG Xiangbin,DENG Jiaqi,ZHANG Pengfei,et al.Clinical Effect of Combined Interferon γ and Mucosolvan Aerosol Inhalation in the Treatment of Acute Attack of Chronic Bronchitis[J].Medical Information,2024,37(04):123.[doi:10.3969/j.issn.1006-1959.2024.20.025]

更新日期/Last Update: 2018-02-15